Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation.

NPJ Breast Cancer · 2021 · PMC7925676 · PMID 33654083

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginally significantP = 0.06so close (0.05 < p ≤ 0.1)

In the analyses of separate SHMs, significantly elevated risks were found for ALL (HR, 3.15; 95% CI, 1.21 to 8.17; P = 0.02) and NHL (HR, 1.33; 95% CI, 1.09 to 1.62; P < 0.001); marginally significant was CML (HR, 1.69; 95% CI, 0.97 to 3.00; P = 0.06) while differences in other SHMs were not significant (Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.